Delivery Order SPE2DR25D2108-SPE2DR26F6SJ4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,109.11 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Gvoke HypoPen 1-Pack 1 mg/0.2 mL auto-injectors. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. This delivery order is a child contract executed...
- The Defense Logistics Agency awarded a delivery order valued at $5,383.14 to AmerisourceBergen Drug Corp for the supply of Gvoke HyperPen 2-Pack 1 mg/0.2 ml auto-injectors on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Gvoke HyperPen is an emergency glucagon auto-injector used to treat...
- This delivery order, awarded on January 13, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides Gvoke HypenPen 2-pack auto-injectors (1 mg/0.2 ml dosage) valued at $2,111.40 with a completion date of January 14, 2026. The award is non-set-aside and structured as a firm fixed-price delivery order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. This contract vehicle, valued at up to $999,999,999.00 and running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL dosage). This is a firm fixed-price delivery order with a ceiling value of $10,843.19 and an ultimate completion date of August 26, 2025. The award was competitively procured with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.18 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 ml) on November 5, 2025, with completion expected by November 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. GVOKE HypoPen is a glucagon auto-injector used for emergency treatment of severe hypoglycemia in patients with diabetes, making...
- The Defense Logistics Agency awarded a $1,734.47 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Gvoke HypoPen auto-injectors (1 mg/0.2 ml, 2-pack). The contract, which represents a non-competitive delivery order under an existing indefinite delivery vehicle, will be fulfilled from the vendor's Conshohocken, Pennsylvania location with a completion date of September 10, 2025. This award is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,558.24 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for Gvoke HypoPen 1-pack 1 mg/0.2 ml auto-injectors, with an ultimate completion date of December 8, 2025. The contract carries no set-aside designation and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.46 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Gvoke HypoPen 2-pack (1 mg/0.2 mL) auto-injectors. The contract, which is not set aside and was competitively awarded, specifies a firm fixed price structure with an ultimate completion date of June 2, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Gvoke HypoGel auto-injector pens (2-pack, 1 mg/0.2 mL formulation) with a ceiling value of $3,957.93. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $16,139.59. This is a firm fixed price delivery order with an ultimate completion date of April 25, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6SJ4Delivery Order
On January 20, 2026, the Defense Logistics Agency awarded a delivery order valued at $11,251.35 to AmerisourceBergen Drug Corp for the supply of Gvoke HyperPen 2-packs (1 mg/0.2 ml) to be delivered to Conshohocken, Pennsylvania. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 21, 2026. The delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Gvoke HyperPen is an emergency glucagon delivery system used to treat severe hypoglycemia in patients with diabetes, making this procurement part of DLA's critical medical supply chain supporting military treatment facilities and veteran healthcare programs. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to efficiently fulfill government requirements for specialty medications and medical devices across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 1/19/26 |